Innovative imaging center awarded $7.1 million

The Molecular Imaging Center at Washington University School of Medicine in St. Louis has received a five-year, $7.1 million grant to develop innovative ways to study cancer and other disorders by monitoring the activity of cells and proteins inside the body.

Fayanju honored for breast cancer research

Oluwadamilola “Lola” Fayanju, MD, MPHS, a clinical research fellow at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, has been named one of 16 recipients of the 2012 Breast Cancer Symposium Merit Award.

Genetic test identifies eye cancer tumors likely to spread

Researchers at Washington University School of Medicine in St. Louis have developed a genetic test that can accurately predict whether the most common form of eye cancer will spread to other parts of the body, particularly the liver. The test successfully classified tumors more than 97 percent of the time.

DNA sequencing lays foundation for personalized cancer treatment

Scientists at Washington University School of Medicine in St. Louis are using powerful DNA sequencing technology not only to identify mutations at the root of a patient’s tumor – considered key to personalizing cancer treatment – but to map the genetic evolution of disease and monitor response to treatment.

New imaging technique moves from lab to clinic

Four applications of the new imaging technique photoacoustic tomography are moving into clinical trials. One is to visualize the sentinel lymph nodes that are important in breast cancer staging; a second to monitor early response to chemotherapy; a third to image melanomas; and the fourth to image the gastrointestinal tract. Biomedical engineer Lihong Wang believes photoacoustic tomography might also allow early diagnosis of cancer because the technique can reveal the hypermetabolism that is cancer’s hallmark.
View More Stories